BioKey (Cayman) Changes Auditor, Engages Kreit & Chiu for FY2026

What Happened

• BioKey (Cayman), Inc. filed an 8-K (filed Aug 6, 2026) reporting that on August 1, 2026 its audit committee approved the dismissal of Simon & Edward, LLP (S&E) and the engagement of Kreit & Chiu CPA LLP (KC) as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
• S&E had served as the company’s auditor from October 17, 2024 through August 1, 2026.

Key Details

• S&E’s audit reports for the fiscal years ended December 31, 2024 and 2025 were not adverse or qualified, but included an explanatory “going concern” paragraph for both years.
• During the two most recent fiscal years and through June 30, 2026, there were no disagreements with S&E on accounting, disclosure, or auditing scope that would have affected its reports.
• There were no “reportable events” under Item 304(a)(1)(v) of Regulation S-K during that period, except for previously disclosed material weaknesses in the company’s internal control over financial reporting.
• The company provided S&E with a copy of the disclosures in the 8-K.

Why It Matters

• A change in independent auditor is a material operational update investors should note. The new engagement means upcoming audited financial statements for FY2026 will be prepared and reviewed by Kreit & Chiu.
• The prior auditor’s going-concern paragraph and the previously disclosed material weaknesses in internal control highlight existing financial and control issues the company has acknowledged — items investors often monitor closely.
• The filing shows an orderly transition (no disagreements reported), but investors may want to watch the next audited financials and any comments from the new auditor for further information about the company’s financial condition and controls.